SEC Form 4 · accession 0001209191-16-111768
NOVAVAX INC · NVAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stanley C Erck
Officer — President and CEO · Director
Period of report
Mar 30, 2016
Accepted (ET)
Apr 1, 2016 · 5:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000694
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 30, 2016 | M | 198,009 | $1.28 | A | 301,066 | D | |
| Common StockF1 | Mar 30, 2016 | S | 198,009 | $5.1917 | D | 103,057 | D | |
| Common Stock | Mar 31, 2016 | M | 201,991 | $1.28 | A | 305,048 | D | |
| Common StockF2 | Mar 31, 2016 | S | 226,769 | $5.1842 | D | 78,279 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F3 | $1.28 | Mar 30, 2016 | M | 198,009 | D | — | Mar 1, 2022 | Common Stock | 198,009 | 701,991 | D |
| Stock Option (Right to buy)F4 | $1.28 | Mar 31, 2016 | M | 201,991 | D | — | Mar 1, 2022 | Common Stock | 201,991 | 500,000 | D |
Explanation of responses
- F1The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.08 to $5.24, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- F2The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.32, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- F3The 198,009 shares exercised on 03/30/2016 pursuant to this stock option vested on 03/01/2013.
- F4Of the 201,991 shares exercised on 03/31/2016 pursuant to this stock option, 26,991 shares vested on 03/01/2013, and the remaining 175,000 shares vested on 03/01/2014.